Acom company collaborates with the following centers:

Washington University St. Louis:
developing synthesis system with Copper 64.

Tennessee University:
new patents on chemical bond between radiopharmaceutical and boron.

Oxford University:
developing new synthesis systems between Copper 64 and sugar derivatives.

ENEA e CERN of Ginevra:
new patents about the fusion of cyclotron and a linear accelerator.

Urbino University:
experimental use of Monoclonal antibody conjugated with 124I.

Camerino University:
experimental use of 64Cu.

Florence University:
experimental use of Iβ cit.

Tor Vergata University, Oncological Hospital of Aviano and IFO Institute:
experimental use of 18F-Colina.